Afimarex 1 mg tablets #30 (Anastrozole)

- Price
- On request
- Brand
- CODEPHARM
- Country
- Uzbekistan
- Minimum order
- 150
- Supplier
- CODEPHARM
- City
- Tashkent
Фармакотерапевтическая группа:
Гормоны
антагонисты и их аналоги. Ферменты ингибиторы.
Trade name of the drug: Afimarex
Active ingredient (INN): anastrozole
Pharmaceutical dosage form: coated tablets
Composition
One tablet contains: active ingredient: anastrozole – 1 mg,
Excipients: Lactose monohydrate, sodium starch glycolate, povidone, magnesium stearate, macrogol 3350, hypromellose, titanium dioxide, triacetin.
Description: tablets, round-shaped, biconvex, white film-coated.
Pharmacotherapeutic group: Hormone antagonists and their analogs. Enzyme inhibitors.
ATC code: L02BG03
Pharmacological properties: Anastrozole is a potent and highly-selective non-steroidal aromatase inhibitor. In postmenopausal women, estradiol is produced mainly in the conversion of androstenedione to estrone through the aromatase enzyme complex in peripheral tissues. Estrone is subsequently transformed into estradiol. The reduction of circulating estradiol levels has a beneficial effect on women with breast cancer. In postmenopausal women, anastrozole at a daily dose of 1 mg caused a suppression of estradiol by more than 80% when using a high-sensitivity analysis.
Anastrozole has no progestogenic, androgenic or estrogenic activity.
Daily doses of anastrozole up to 10 mg do not affect the secretion of cortisol or aldosterone.
Pharmacokinetics: Inhibition of aromatase activity is produced mainly through the anastrozole parent drug. Orally administrated anastrozole is well absorbed by the circulatory system, with 83 – 85% recovered in urine and faeces. Food does not affect the extent of absorption. Anastrozole elimination occurs mainly through hepatic metabolism (approximately 85%) and, to a smaller extent, through renal excretion (about 11%). The average half-life of anastrozole in postmenopausal women is about 50 hours. The main circulating metabolite of anastrozole – triazole – has no pharmacological activity. Pharmacokinetics of anastrozole is linear over a range of doses from 1 mg to 20 mg, and does not change for repeated doses. The half-life is of 2 days, in which the plasma concentration levels approach the established levels after 7 days of dosing once daily. Steady-state levels are three to four times higher than the levels observed after a single dose of anastrozole. In the therapeutic range, about 40% of anastrozole binds with plasma proteins. Anastrozole is extensively metabolized, with about 10% of the dose excreted in the urine as an unchanged drug within 72 hours of dosing, and the remainder (about 60% of the dose) excreted in urine as metabolites.
Metabolism of anastrozole if realized through N-dealkylation, hydroxylation and glucuronidation. In plasma and urine metabolites, three anastrozole metabolites were identified. The identified metabolites are triazole, glucuronide conjugate of hydroxy-anastrozole and anastrozole glucuronide directly.
Since excretion through the kidneys is not the principal elimination method, anastrozole total clearance remains unchanged even in severe (creatinine clearance less than 30 mL / min / 1,73m2) renal insufficiency. Regular dosage for patients with renal dysfunction, as well as those with stable cirrhotic is not required.
Directions for usage
— Breast cancer of advanced stage in postmenopausal period
— Adjuvant Treatment of postmenopausal women with positive receptor status of Breast cancer in the early invasive stages
Early breast cancer in postmenopausal women with positive receptor status, after 2-3 years of adjuvant tamoxifen therapy
Dosage and method of administration:
The drug is administered orally. The tablet is taken with water. The medication is taken always at the same time, regardless of meals.
Adults, including elderly people, take 1 mg orally daily for a long time. If there are signs of progression of the disease, taking the drug should be stopped. As an adjuvant therapy, recommended duration of treatment is of 5 years.
Dose adjustment in patients with impaired renal function is not required. Dose adjustment in…
Specifications
- Сертификат
- Возможные объемы поставки:
- 2000упак. / за неделю
- Методы оплаты:
- банковский перевод
- Возможные методы транспортировки:
- авто транспорт, самовывоз
Similar products
SWEET BABY BABY DIAPERS70 000 UZS
Infusion system1 150 UZS
DZ-1-CO carbon monoxide (CO) gas alarm (detector)
SOU1 carbon monoxide detector CO
ANKAT-7635S mokerlyzer - indicator of carbon monoxide in exhaled air
Filter cartridge replaceable standard in film with euroslot Barrier83 283,2 UZS
Irradiator-Recirculator Eco Recirc Uvc 2x30w Wt F K Vs1 Ru Ledv.3 225 212,9 UZS
Thermometer infrared UNI-T UT306A343 188,3 UZS
Interventional Radiology at ANADOLU Medical Center (Türkiye)
Hitoycha becomes massage. 128 methods of swimming for children who are divided into four groups
Glucose HK-Abris+, Hexokinase-glucose-6-phosphate dehydrogenase enzymatic reference method. Reagent kit for determining glucose concentration in biological fluids
Packaging for pacifiers
Plater 75 mg. Tablets No. 28 (Clopidogrel) - antiplatelet agents
Azofrin 500 mg. Tablets No. 3 (Azithromycin) - Antibiotics (macrolide group)